English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52757702    線上人數 :  586
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 336-345 / 1656 (共166頁)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-08-31T05:27:01Z Idiopathic hypereosinophilic syndrome with Löeffler's endocarditis LI-TAN YANG; Tsai S.-H.; Tsai Y.-S.; Liao I.-C.; Hsu C.-H.; Tsai W.-C.; Dr.
臺大學術典藏 2021-08-18T07:39:09Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma JHE-CYUAN GUO; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-08-18T07:39:08Z Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer Yang S.-H.; Kuo T.-C.; Wu H.; JHE-CYUAN GUO; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2021-08-18T07:39:07Z Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma Yang P.-C.; JHE-CYUAN GUO; Hsieh M.-S.; Lin C.-C.; Hsu C.-H.
臺大學術典藏 2021-08-18T07:39:06Z Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy JHE-CYUAN GUO; Lin C.-C.; Huang T.-C.; Huang P.-M.; Kuo H.-Y.; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; Lee J.-M.
臺大學術典藏 2021-08-18T07:39:05Z Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; JHE-CYUAN GUO; Liu T.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-08-18T07:39:05Z Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors JHE-CYUAN GUO; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; Kuo H.-Y.; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H.
臺大學術典藏 2021-08-18T07:39:03Z Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives Kuo H.-Y.; JHE-CYUAN GUO; Hsu C.-H.
臺大學術典藏 2021-08-17T03:11:23Z Activating natural killer (NK) cytotoxicity of canine CD5-CD21- cells requires low surface CD5 density NK cells Lin, C. S.; Chang, C. P.; Chiang, H. C.; Chuang, T. F.; Hsu, C. H.; Liu, C. C.
臺大學術典藏 2021-08-12T04:01:31Z Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials YANG SHIH-HUNG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L.

顯示項目 336-345 / 1656 (共166頁)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
每頁顯示[10|25|50]項目